Senseonics Holdings (SENS) Announces FDA Approval of World's First Long-Term Implantable Continuous Glucose Monitoring System
Senseonics Holdings, Inc. (NYSE: SENS) today announced the U.S. Food and Drug Administration has approved its Premarket Approval (PMA) ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)